Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stanke-Labesque

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|May 21, 2014
CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicityM Roustit, X Fonrose, D Montani, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2001
Increased lipid peroxidation in patients with pulmonary hypertensionJ L Cracowski, C Cracowski, G Bessard, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2012
Therapeutic drug monitoring of posaconazole in allogeneic hematopoietic stem cell transplantation patients who develop gastrointestinal graft-versus-host diseaseJ Tonini, A Thiébaut, J F Jourdil, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic ratsG Hardy, F Stanke-Labesque, M Peoc'h, et al.
Journal of Cardiovascular Pharmacology|August 3, 2001
Formation of isoprostanes in children with type IIa hypercholesterolemiaJ L Cracowski, D Ploin, J Bessard, et al.
The European Respiratory Journal|March 7, 2008
Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?B Lefebvre, J-L Pépin, J-P Baguet, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 25, 2004
Chronic intermittent hypoxia increases infarction in the isolated rat heartM Joyeux-Faure, F Stanke-Labesque, B Lefebvre, et al.
Diabetes & Metabolism|March 4, 2014
Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: the VARIAFIT studyP Y Benhamou, F Somers, S Lablanche, et al.
Clinical Pharmacology and Therapeutics|January 25, 2014
Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept studyM Roustit, F Gaillard-Bigot, S Blaise, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|May 21, 2014
CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicityM Roustit, X Fonrose, D Montani, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2001
Increased lipid peroxidation in patients with pulmonary hypertensionJ L Cracowski, C Cracowski, G Bessard, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2012
Therapeutic drug monitoring of posaconazole in allogeneic hematopoietic stem cell transplantation patients who develop gastrointestinal graft-versus-host diseaseJ Tonini, A Thiébaut, J F Jourdil, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic ratsG Hardy, F Stanke-Labesque, M Peoc'h, et al.
Journal of Cardiovascular Pharmacology|August 3, 2001
Formation of isoprostanes in children with type IIa hypercholesterolemiaJ L Cracowski, D Ploin, J Bessard, et al.
The European Respiratory Journal|March 7, 2008
Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?B Lefebvre, J-L Pépin, J-P Baguet, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 25, 2004
Chronic intermittent hypoxia increases infarction in the isolated rat heartM Joyeux-Faure, F Stanke-Labesque, B Lefebvre, et al.
Diabetes & Metabolism|March 4, 2014
Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: the VARIAFIT studyP Y Benhamou, F Somers, S Lablanche, et al.
Clinical Pharmacology and Therapeutics|January 25, 2014
Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept studyM Roustit, F Gaillard-Bigot, S Blaise, et al.
Pageof 4